Literature DB >> 29350500

Global Advisory Committee on Vaccine Safety, 6–7 December 2017.

.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29350500

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  8 in total

1.  Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.

Authors:  Jean Claude Dejon-Agobe; Ulysse Ateba-Ngoa; Albert Lalremruata; Andreas Homoet; Julie Engelhorn; Odilon Paterne Nouatin; Jean Ronald Edoa; José F Fernandes; Meral Esen; Yoanne Darelle Mouwenda; Eunice M Betouke Ongwe; Marguerite Massinga-Loembe; Stephen L Hoffman; B Kim Lee Sim; Michael Theisen; Peter G Kremsner; Ayôla A Adegnika; Bertrand Lell; Benjamin Mordmüller
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 2.  Novel vaccine safety issues and areas that would benefit from further research.

Authors:  Daniel A Salmon; Paul Henri Lambert; Hanna M Nohynek; Julianne Gee; Umesh D Parashar; Jacqueline E Tate; Annelies Wilder-Smith; Kenneth Y Hartigan-Go; Peter G Smith; Patrick Louis F Zuber
Journal:  BMJ Glob Health       Date:  2021-05

3.  Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.

Authors:  Adam L Cohen; Negar Aliabadi; Fatima Serhan; Jacqueline E Tate; Patrick Zuber; Umesh D Parashar
Journal:  Vaccine       Date:  2018-08-18       Impact factor: 4.169

4.  Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.

Authors:  Viviane Jusot; Frider Chimimba; Nettie Dzabala; Olga Menang; Joy Cole; Gregory Gardiner; Opokua Ofori-Anyinam; Olakunle Oladehin; Cecilia Sambakunsi; Mphatso Kawaye; Jens-Ulrich Stegmann; Yolanda Guerra Mendoza
Journal:  Drug Saf       Date:  2020-06       Impact factor: 5.606

5.  Letter to the editor concerning the article 'Association between rotavirus vaccination and risk of intussusception among neonates and infants: a systematic review and meta-analysis' (JAMA Netw Open. 2019;2(10):e1912458).

Authors:  Bernd Benninghoff; Priya Pereira; Corinne Willame
Journal:  Hum Vaccin Immunother       Date:  2020-03-18       Impact factor: 3.452

6.  Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level phase III data.

Authors:  Daniel J Laydon; Ilaria Dorigatti; Wes R Hinsley; Gemma Nedjati-Gilani; Laurent Coudeville; Neil M Ferguson
Journal:  Elife       Date:  2021-07-02       Impact factor: 8.140

7.  A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.

Authors:  Catherine Cohet; Brigitte Cheuvart; Leentje Moerman; Dan Bi; Adrian Caplanusi; Mallesh Kariyappa; Sanjay Lalwani; Monjori Mitra; Amita Sapru; Shruti Saha; P V Varughese; Rajeev Zachariah Kompithra; Sanjay Gandhi
Journal:  Hum Vaccin Immunother       Date:  2021-08-24       Impact factor: 3.452

Review 8.  Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.

Authors:  Volker Vetter; Robert C Gardner; Serge Debrus; Bernd Benninghoff; Priya Pereira
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.